A Study to Learn How the Study Medicine Called [14C]PF-07054894 is Processed by the Body

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 20, 2025

Primary Completion Date

August 20, 2025

Study Completion Date

September 11, 2025

Conditions
Healthy
Interventions
DRUG

PF-07054894

"Cohort 1 Period 1 - Oral \[cyclobutenyl-14C\]PF-07054894 under fasted state. Cohort 1 Period 2: Oral unlabeled PF-07054894 followed by IV \[cyclobutenyl-14C\]PF-07054894 fusion over approximately 15 minutes at approximately 1.5 hours after the administration of the oral unlabeled dose.~Cohort 1 Period 2: Oral unlabeled PF-07054894 followed by IV \[cyclobutenyl-14C\]PF-07054894 fusion over approximately 15 minutes at approximately 1.5 hours after the administration of the oral unlabeled dose."

DRUG

PF-07054894

Cohort 2 Period 1 - Oral \[Methyl-14C\]PF-07054894 under fasted state.

Trial Locations (1)

9728 NZ

ICON, Groningen

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT07009353 - A Study to Learn How the Study Medicine Called [14C]PF-07054894 is Processed by the Body | Biotech Hunter | Biotech Hunter